Dimensional Fund Advisors
RVNC

Dimensional Fund Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Dimensional Fund Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-98,129
Closed -$1.91M – 3541
2022
Q1 		$1.91M Sell
98,129
-33,532
-25% -$509K ﹤0.01% 2847
2021
Q4 		$2.15M Buy
131,661
+8,801
+7% +$147K ﹤0.01% 2837
2021
Q3 		$3.42M Sell
122,860
-26,824
-18% -$765K ﹤0.01% 2685
2021
Q2 		$4.44M Buy
+149,684
New +$4.32M ﹤0.01% 2649
2021
Q1 		– Sell
-487,436
Closed -$13.8M – 3425
2020
Q4 		$13.8M Sell
487,436
-143,779
-23% -$3.72M 0.01% 2149
2020
Q3 		$15.9M Sell
631,215
-8,646
-1% -$227K 0.01% 1969
2020
Q2 		$15.6M Buy
639,861
+48,098
+8% +$949K 0.01% 1992
2020
Q1 		$8.76M Sell
591,763
-1,901
-0.3% -$39.3K ﹤0.01% 2184
2019
Q4 		$9.63M Buy
593,664
+121,018
+26% +$1.88M ﹤0.01% 2364
2019
Q3 		$6.14M Buy
472,646
+82,318
+21% +$1.01M ﹤0.01% 2532
2019
Q2 		$5.06M Buy
390,328
+16,424
+4% +$207K ﹤0.01% 2633
2019
Q1 		$5.89M Buy
373,904
+148,196
+66% +$2.57M ﹤0.01% 2592
2018
Q4 		$4.54M Buy
225,708
+149,952
+198% +$3.3M ﹤0.01% 2639
2018
Q3 		$1.88M Buy
+75,756
New +$2.06M ﹤0.01% 2941

Other funds holding RVNC

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Dimensional Fund Advisors's RVNC Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2022, closing a stake of 98,129 shares — an estimated $1.91M sold.

Dimensional Fund Advisors first reported a position in RVNC in Q3 2018 and held it in 14 quarters. The position peaked at $15.9M in Q3 2020. 161 funds tracked by Wall St. Rank hold RVNC as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Revance Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 98,129 Revance Therapeutics, Inc. shares in Q2 2022, an estimated $1.91M.
  • Dimensional Fund Advisors first reported a position in Revance Therapeutics, Inc. in Q3 2018 and held it in 14 quarters.
  • Dimensional Fund Advisors's Revance Therapeutics, Inc. position peaked at $15.9M in Q3 2020.
  • 161 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.